8-K

                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                    FORM 8-K

                                 CURRENT REPORT
     Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

                Date of Report (Date of earliest event reported):
                                August 19, 2002

                                MANOR CARE, INC.
             (Exact name of registrant as specified in its charter)


Delaware                           1-10858                   34-1687107
(State or other jurisdiction       (Commission               (IRS Employer
of incorporation)                  File Number)              Identification No.)


         333 N. Summit Street, Toledo, Ohio          43604-2617
         (Address of principal executive offices)    (Zip Code)



Registrant's telephone number, including area code:  (419) 252-5500





ITEM 5.  OTHER EVENTS

         On August 16, 2002, Manor Care, Inc. and Genesis Health Ventures, Inc.
announced that they are withdrawing all outstanding legal actions against each
other and have executed a new pharmacy agreement. A copy of this press release
is filed herewith as Exhibit 99.1.

ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

(c) Exhibit.

99.1     Press Release dated August 16, 2002 of Manor Care, Inc.










                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                   Manor Care, Inc.
                                   (Registrant)

Date: August 19, 2002              By:    /s/ R. Jeffrey Bixler
                                          --------------------------------------
                                          R. Jeffrey Bixler, Vice President,
                                          General Counsel and Secretary







                                  EXHIBIT INDEX


Exhibit
Number              Description
- ------              -----------

99.1     Press Release dated August 16, 2002 of Manor Care, Inc.

EX-99.1

                                                                    Exhibit 99.1

                                                                       MANORCARE
                                                                    News Release


FOR IMMEDIATE RELEASE

CONTACT:
Geoffrey G. Meyers, Chief Financial Officer
419-252-5545
e-mail  gmeyers@hcr-manorcare.com
        -------------------------

Genesis:  George V. Hager, Jr.
EVP & CFO
610-444-6350


 MANOR CARE AND GENESIS END LEGAL DISPUTES; SIGN NEW PHARMACY SERVICES AGREEMENT

      TOLEDO, OH, and Kennett Square, PA - August 16, 2002 - Manor Care Inc.
(NYSE:HCR) and Genesis Health Ventures, Inc. (NASDAQ:GHVI) today announced that
they are withdrawing all outstanding legal actions against each other and have
executed a new pharmacy agreement.
         The parties have agreed to withdraw all pending litigation stemming
from NeighborCare's acquisition of Manor Care's pharmacy subsidiary, Vitalink,
in 1998 and the prior pharmacy agreement.
      The new pharmacy agreement between Genesis' pharmacy subsidiary,
NeighborCare, and Manor Care will run through January, 2006, and covers
approximately 200 Manor Care facilities in 20 states. The new agreement replaces
the current agreement between the two companies that was set to expire in 2004.
The new arrangement is the result of extensive dialogue between the two
companies and represents a completely new and mutually beneficial relationship.
      Paul Ormond, Manor Care's chairman, president and chief executive officer
said, "This agreement brings to a close a long series of differences between the
companies and normalizes the competitive aspects of the business relationship."
      "The collaborative effort involved in reaching this new pharmacy agreement
is a clear indication that Genesis and Manor Care leadership have put aside any
past differences and have begun a new, productive, long-term relationship," said
Robert Fish, interim Genesis CEO.



      Manor Care, Inc., through its operating group HCR Manor Care, is the
leading owner and operator of long-term care centers in the United States. The
company's 59,000 employees provide high-quality care for patients, residents and
clients through a network of more than 500 long-term care centers, assisted
living facilities, outpatient rehabilitation clinics and home health care and
hospice offices. Alliances and other ventures supply high-quality pharmaceutical
products and management services for professional organizations. The company
operates primarily under the respected Heartland, ManorCare and Arden Courts
names. Manor Care is committed to being the preeminent care provider in the
industry. Shares are traded on the New York Stock Exchange under the ticker
symbol HCR.
      Genesis Health Ventures is a leading provider of healthcare services to
America's elders through a network of NeighborCare pharmacies and Genesis
ElderCare skilled nursing and assisted living facilities. In addition to
pharmacy and in-patient eldercare services, Genesis' 46,000 employees also
provide rehabilitation and hospitality services, group purchasing, consulting,
and facility management services to long-term care providers nationwide.
Additional information, including investor information, is available on the
Genesis web site at www.ghv.com.
      Statements made in this release, and in our other public filings and
releases, which are not historical facts, contain "forward-looking" statements
(as defined in the Private Securities Litigation Reform Act of 1995) that
involve risks and uncertainties and are subject to change at any time. These
forward-looking statements may include, but are not limited to statements
containing words such as "anticipate," "believe," "plan," "estimate," "expect,"
"intend," "may" and similar expressions. Factors that could cause actual results
to differ materially include, but are not limited to, the following: changes in
the reimbursement rates or methods of payment from Medicate or Medicaid, or the
implementation of other measures to reduce reimbursement for our services;
changes in pharmacy legislation and payment formulas; the expiration of
enactments providing for additional government funding; efforts of third party
payors to control costs; the impact of federal and state regulations; changes in
payor mix and payment methodologies; further consolidation of managed care
organizations and other third party payors; competition in our business; an
increase in insurance costs and potential liability for losses not covered by,
or in excess of, our insurance; competition for qualified staff in the
healthcare industry; our ability to control operating costs and generate
sufficient cash flow to meet



operational and financial requirements; and an economic downturn or changes in
the laws affecting our business in those markets in which we operate.
      The forward-looking statements involve known and unknown risks,
uncertainties and other factors that are, in some cases, beyond our control. We
caution investors that any forward-looking statements made by us are no
guarantees of future performance. We disclaim any obligation to update any such
factors or to announce publicly the results of any revision to any of the
forward-looking statements to reflect future events or developments.

                                      -30-